Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshimi Arima

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Pharmacology & Therapeutics|July 31, 2007
The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?Christian Bronner, Mayada Achour, Yoshimi Arima, et al.
The Journal of Biological Chemistry|December 23, 2003
Activation of m-calpain is required for chromosome alignment on the metaphase plate during mitosisShinobu Honda, Tomotoshi Marumoto, Toru Hirota, et al.
Cancer Research|July 3, 2008
Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transitionYoshimi Arima, Yasumichi Inoue, Tatsuhiro Shibata, et al.
Biomedicines|December 23, 2022
Pixel-Level Clustering of Hematoxylin-Eosin-Stained Sections of Mouse and Human Biliary Tract CancerHaruki Inoue, Eriko Aimono, Akiyoshi Kasuga, et al.
Experimental Dermatology|December 17, 2009
Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1Yoshimi Arima, Hidemi Hayashi, Kanako Kamata, et al.
Cancers|May 28, 2022
Mutation of <i>PTPN11</i> (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to <i>BRAP</i> MutationRitsuko Harigai, Ryo Sato, Chikako Hirose, et al.
International Journal of Oncology|November 8, 2006
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
The Journal of Biological Chemistry|March 9, 2005
Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondriaYoshimi Arima, Masayuki Nitta, Shinji Kuninaka, et al.
The Journal of Urology|February 14, 2007
Identification of target antigens in specific immunotherapy for renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 11, 2004
Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transitionYoshimi Arima, Toru Hirota, Christian Bronner, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Pharmacology & Therapeutics|July 31, 2007
The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?Christian Bronner, Mayada Achour, Yoshimi Arima, et al.
The Journal of Biological Chemistry|December 23, 2003
Activation of m-calpain is required for chromosome alignment on the metaphase plate during mitosisShinobu Honda, Tomotoshi Marumoto, Toru Hirota, et al.
Cancer Research|July 3, 2008
Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transitionYoshimi Arima, Yasumichi Inoue, Tatsuhiro Shibata, et al.
Biomedicines|December 23, 2022
Pixel-Level Clustering of Hematoxylin-Eosin-Stained Sections of Mouse and Human Biliary Tract CancerHaruki Inoue, Eriko Aimono, Akiyoshi Kasuga, et al.
Experimental Dermatology|December 17, 2009
Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1Yoshimi Arima, Hidemi Hayashi, Kanako Kamata, et al.
Cancers|May 28, 2022
Mutation of <i>PTPN11</i> (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to <i>BRAP</i> MutationRitsuko Harigai, Ryo Sato, Chikako Hirose, et al.
International Journal of Oncology|November 8, 2006
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
The Journal of Biological Chemistry|March 9, 2005
Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondriaYoshimi Arima, Masayuki Nitta, Shinji Kuninaka, et al.
The Journal of Urology|February 14, 2007
Identification of target antigens in specific immunotherapy for renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 11, 2004
Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transitionYoshimi Arima, Toru Hirota, Christian Bronner, et al.
Pageof 4